Synthonics, Inc

Synthonics, Inc. is a privately-held specialty pharmaceutical company focused on the discovery and development of patentable drugs that incorporate our proprietary metal coordination chemistry. We bind metals to known pharmaceutical agents to create new products that are better absorbed and thus have greater therapeutic benefits than their predecessors. Although our chemistry has broad application, were preliminarily focused on drugs, such as T3 (liothyronine) and levodopa, whose short half-life limits their clinical utility. S

Synthonics, inc operates in the Biotechnology research industry.

Synthonics, inc's revenue is 11m - 100m

Synthonics, inc has 11 - 50 employees.